Skip to main content
Erschienen in: Journal of Cancer Education 2/2017

30.01.2017

A Review of Shared Decision-Making and Patient Decision Aids in Radiation Oncology

verfasst von: Kristina Demas Woodhouse, Katie Tremont, Anil Vachani, Marilyn M. Schapira, Neha Vapiwala, Charles B. Simone II, Abigail T. Berman

Erschienen in: Journal of Cancer Education | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Cancer treatment decisions are complex and may be challenging for patients, as multiple treatment options can often be reasonably considered. As a result, decisional support tools have been developed to assist patients in the decision-making process. A commonly used intervention to facilitate shared decision-making is a decision aid, which provides evidence-based outcomes information and guides patients towards choosing the treatment option that best aligns with their preferences and values. To ensure high quality, systematic frameworks and standards have been proposed for the development of an optimal aid for decision making. Studies have examined the impact of these tools on facilitating treatment decisions and improving decision-related outcomes. In radiation oncology, randomized controlled trials have demonstrated that decision aids have the potential to improve patient outcomes, including increased knowledge about treatment options and decreased decisional conflict with decision-making. This article provides an overview of the shared-decision making process and summarizes the development, validation, and implementation of decision aids as patient educational tools in radiation oncology. Finally, this article reviews the findings from decision aid studies in radiation oncology and offers various strategies to effectively implement shared decision-making into clinical practice.
Literatur
11.
Zurück zum Zitat Alden DL, Friend J, Schapira M, Stiggelbout A (2014) Cultural targeting and tailoring of shared decision making technology: a theoretical framework for improving the effectiveness of patient decision aids in culturally diverse groups. Soc Sci Med 105:1–8. doi:10.1016/j.socscimed.2014.01.002 CrossRefPubMed Alden DL, Friend J, Schapira M, Stiggelbout A (2014) Cultural targeting and tailoring of shared decision making technology: a theoretical framework for improving the effectiveness of patient decision aids in culturally diverse groups. Soc Sci Med 105:1–8. doi:10.​1016/​j.​socscimed.​2014.​01.​002 CrossRefPubMed
15.
Zurück zum Zitat Levit L, Balogh E, Nass S, Ganz PA, Institute of Medicine (IOM) (2013) Delivering high-quality cancer care: charting a new course for a system in crisis. National Academies Press, US. doi:10.17226/18359 CrossRef Levit L, Balogh E, Nass S, Ganz PA, Institute of Medicine (IOM) (2013) Delivering high-quality cancer care: charting a new course for a system in crisis. National Academies Press, US. doi:10.​17226/​18359 CrossRef
22.
Zurück zum Zitat Tariman JD, Berry DL, Cochrane B, Doorenbos A, Schepp K (2010) Preferred and actual participation roles during health care decision making in persons with cancer: a systematic review. Ann Oncol 21(6):1145–1151. doi:10.1093/annonc/mdp534 CrossRefPubMed Tariman JD, Berry DL, Cochrane B, Doorenbos A, Schepp K (2010) Preferred and actual participation roles during health care decision making in persons with cancer: a systematic review. Ann Oncol 21(6):1145–1151. doi:10.​1093/​annonc/​mdp534 CrossRefPubMed
23.
Zurück zum Zitat O’Connor AM, Bennett C, Stacey D et al Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Mak 27(5):554–574. doi:10.1177/0272989X07307319 O’Connor AM, Bennett C, Stacey D et al Do patient decision aids meet effectiveness criteria of the international patient decision aid standards collaboration? A systematic review and meta-analysis. Med Decis Mak 27(5):554–574. doi:10.​1177/​0272989X07307319​
29.
Zurück zum Zitat Davison BJ, Goldenberg SL, Wiens KP, Gleave ME Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer. Cancer Nurs 30(5):E7–15. doi:10.1097/01.NCC.0000290819.22195.d6 Davison BJ, Goldenberg SL, Wiens KP, Gleave ME Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer. Cancer Nurs 30(5):E7–15. doi:10.​1097/​01.​NCC.​0000290819.​22195.​d6
30.
Zurück zum Zitat Hack TF, Pickles T, Bultz BD, Ruether JD, Degner LF (2007) Impact of providing audiotapes of primary treatment consultations to men with prostate cancer: a multi-site, randomized, controlled trial. Psychooncology 16(6):543–552. doi:10.1002/pon.1094 Hack TF, Pickles T, Bultz BD, Ruether JD, Degner LF (2007) Impact of providing audiotapes of primary treatment consultations to men with prostate cancer: a multi-site, randomized, controlled trial. Psychooncology 16(6):543–552. doi:10.​1002/​pon.​1094
31.
Zurück zum Zitat Berry DL, Halpenny B, Hong F et al (2013) The personal patient profile-prostate decision support for men with localized prostate cancer: a multi-center randomized trial. Urol Oncol 31(7):1012–1021. doi:10.1016/j.urolonc.2011.10.004 Berry DL, Halpenny B, Hong F et al (2013) The personal patient profile-prostate decision support for men with localized prostate cancer: a multi-center randomized trial. Urol Oncol 31(7):1012–1021. doi:10.​1016/​j.​urolonc.​2011.​10.​004
33.
34.
Zurück zum Zitat Lam WWT, Chan M, Or A, Kwong A, Suen D, Fielding R (2013) Reducing treatment decision conflict difficulties in breast cancer surgery: a randomized controlled trial. J Clin Oncol 31(23):2879–2885. doi:10.1200/JCO.2012.45.1856 Lam WWT, Chan M, Or A, Kwong A, Suen D, Fielding R (2013) Reducing treatment decision conflict difficulties in breast cancer surgery: a randomized controlled trial. J Clin Oncol 31(23):2879–2885. doi:10.​1200/​JCO.​2012.​45.​1856
35.
Zurück zum Zitat Hawley ST, Newman L, Griggs JJ, Kosir MA, Katz SJ (2016) Evaluating a decision aid for improving decision making in patients with early-stage breast cancer. Patient 9(2):161–169. doi:10.1007/s40271-015-0135-y Hawley ST, Newman L, Griggs JJ, Kosir MA, Katz SJ (2016) Evaluating a decision aid for improving decision making in patients with early-stage breast cancer. Patient 9(2):161–169. doi:10.​1007/​s40271-015-0135-y
38.
Zurück zum Zitat Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA (2009) Patient decision aids for prostate cancer treatment: a systematic review of the literature. CA Cancer J Clin 59(6):379–390. doi:10.3322/caac.20039 Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA (2009) Patient decision aids for prostate cancer treatment: a systematic review of the literature. CA Cancer J Clin 59(6):379–390. doi:10.​3322/​caac.​20039
39.
Zurück zum Zitat Shabason JE, Mao JJ, Frankel ES, Vapiwala N (2014) Shared decision-making and patient control in radiation oncology: implications for patient satisfaction. Cancer 120(12):1863–1870. doi:10.1002/cncr.28665 Shabason JE, Mao JJ, Frankel ES, Vapiwala N (2014) Shared decision-making and patient control in radiation oncology: implications for patient satisfaction. Cancer 120(12):1863–1870. doi:10.​1002/​cncr.​28665
40.
Zurück zum Zitat Leighl NB, Butow PN, Tattersall MHN (2004) Treatment decision aids in advanced cancer: when the goal is not cure and the answer is not clear. J Clin Oncol 22(9):1759–1762. doi:10.1200/JCO.2004.02.166 Leighl NB, Butow PN, Tattersall MHN (2004) Treatment decision aids in advanced cancer: when the goal is not cure and the answer is not clear. J Clin Oncol 22(9):1759–1762. doi:10.​1200/​JCO.​2004.​02.​166
41.
Zurück zum Zitat Brundage MD, Feldman-Stewart D, Cosby R et al (2001) Cancer patients’ attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support. Patient Educ Couns 45(2):149–157. doi:10.1016/S0738-3991(01)00155-0 Brundage MD, Feldman-Stewart D, Cosby R et al (2001) Cancer patients’ attitudes toward treatment options for advanced non-small cell lung cancer: implications for patient education and decision support. Patient Educ Couns 45(2):149–157. doi:10.​1016/​S0738-3991(01)00155-0
42.
Zurück zum Zitat Dharmarajan KV, McCormick B, Walters C, Monether C, Levin T, Milazzo CA, Rawlins-Duell R, Giannantoni-Ibelli G (2013) Use of a video decision tool to improve informed decision making in hospitalized patients considering palliative radiation therapy. J Clin Oncol 31:29 Dharmarajan KV, McCormick B, Walters C, Monether C, Levin T, Milazzo CA, Rawlins-Duell R, Giannantoni-Ibelli G (2013) Use of a video decision tool to improve informed decision making in hospitalized patients considering palliative radiation therapy. J Clin Oncol 31:29
43.
Zurück zum Zitat Sze J, Marisette S, Williams D et al (2006) Decision making in palliative radiation therapy: reframing hope in caregivers and patients with brain metastases. Support Care Cancer 14(10):1055–1063. doi:10.1007/s00520-006-0032-y Sze J, Marisette S, Williams D et al (2006) Decision making in palliative radiation therapy: reframing hope in caregivers and patients with brain metastases. Support Care Cancer 14(10):1055–1063. doi:10.​1007/​s00520-006-0032-y
44.
Zurück zum Zitat Kane HL, Halpern MT, Squiers LB, Treiman KA, McCormack LA Implementing and evaluating shared decision making in oncology practice. CA Cancer J Clin 64(6):377–388. doi:10.3322/caac.21245 Kane HL, Halpern MT, Squiers LB, Treiman KA, McCormack LA Implementing and evaluating shared decision making in oncology practice. CA Cancer J Clin 64(6):377–388. doi:10.​3322/​caac.​21245
45.
Zurück zum Zitat Spiegle G, Al-Sukhni E, Schmocker S et al (2013) Patient decision aids for cancer treatment: are there any alternatives? Cancer 119(1):189–200. doi:10.1002/cncr.27641 Spiegle G, Al-Sukhni E, Schmocker S et al (2013) Patient decision aids for cancer treatment: are there any alternatives? Cancer 119(1):189–200. doi:10.​1002/​cncr.​27641
48.
Zurück zum Zitat Hopmans W, Damman OC, Porsius JT, Zwaan L, Senan S, Timmermans DRM (2016) Treatment recommendations by clinicians in stage I non-small cell lung cancer: a study of factors that influence the likelihood of accounting for the patient’s preference. Patient Educ Couns 99(11):1808–1813. doi:10.1016/j.pec.2016.05.017 Hopmans W, Damman OC, Porsius JT, Zwaan L, Senan S, Timmermans DRM (2016) Treatment recommendations by clinicians in stage I non-small cell lung cancer: a study of factors that influence the likelihood of accounting for the patient’s preference. Patient Educ Couns 99(11):1808–1813. doi:10.​1016/​j.​pec.​2016.​05.​017
49.
Zurück zum Zitat Stevenson FA, Cox K, Britten N, Dundar Y (2004) A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect 7(3):235–245. doi:10.1111/j.1369-7625.2004.00281.x Stevenson FA, Cox K, Britten N, Dundar Y (2004) A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect 7(3):235–245. doi:10.​1111/​j.​1369-7625.​2004.​00281.​x
Metadaten
Titel
A Review of Shared Decision-Making and Patient Decision Aids in Radiation Oncology
verfasst von
Kristina Demas Woodhouse
Katie Tremont
Anil Vachani
Marilyn M. Schapira
Neha Vapiwala
Charles B. Simone II
Abigail T. Berman
Publikationsdatum
30.01.2017
Verlag
Springer US
Erschienen in
Journal of Cancer Education / Ausgabe 2/2017
Print ISSN: 0885-8195
Elektronische ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-017-1169-8

Weitere Artikel der Ausgabe 2/2017

Journal of Cancer Education 2/2017 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.